chr16:55478971:> Detail (hg38) (MMP2)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr16:55,512,883-55,540,603 |
| hg38 | chr16:55,478,971-55,506,691 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
| Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| inflammatory breast carcinoma | Bevacizumab | B |
Predictive
|
Supports
|
Sensitivity/Response |
N/A
|
3 | 26921265 | Detail |
| brain glioma | Bevacizumab | B |
Predictive
|
Supports
|
Sensitivity/Response |
N/A
|
2 | 24327581 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| MMP2 serum levels were assessed (ELISA) at baseline (b) and before surgery in 45 available samples f... | CIViC Evidence | Detail |
| Plasma levels of 11 potential biomarkers were tested at baseline and 2 weeks after bevacizumab initi... | CIViC Evidence | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg38
- Position
- chr16:55,478,971-55,506,691
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- SERUM LEVELS
- Transcript 1 (CIViC Variant)
- ENST00000219070.4
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/487
Genome browser